Abstract

Synchronous carcinomas involving both the ovary and uterine corpus are relatively uncommon. These tumours represent a diagnostic and therapeutic challenge, particularly if they have similar histology. Here we present the case of a 34-year-old woman with bilateral endometrioid cancers of both ovaries and adenocarcinoma of the uterus.

Publication details

DOI
10.18295/2075-0528.2580
Journal
Sultan Qaboos University Medical Journal, 3(1), 51-53
Publisher
Sultan Qaboos University
Open access
Gold open access
License
CC BY-ND 4.0

Cite this article

APA 7

Al-Moundhri, M., Mathew, M., & Andrzej (2025). Synchronous bilateral endometrioid ovarian cancer and uterine adeno carcinoma in a young woman. Sultan Qaboos University Medical Journal, 3(1), 51-53. https://doi.org/10.18295/2075-0528.2580

MLA 9

Al-Moundhri, Mansour, et al. "Synchronous bilateral endometrioid ovarian cancer and uterine adeno carcinoma in a young woman." Sultan Qaboos University Medical Journal, vol. 3, no. 1, 2025, pp. 51-53. https://doi.org/10.18295/2075-0528.2580.

Chicago (author–date)

Al-Moundhri, Mansour, Mariam Mathew, and Andrzej. 2025. "Synchronous bilateral endometrioid ovarian cancer and uterine adeno carcinoma in a young woman." Sultan Qaboos University Medical Journal 3 (1): 51-53. https://doi.org/10.18295/2075-0528.2580.

Harvard

Al-Moundhri, M., Mathew, M. and Andrzej (2025) 'Synchronous bilateral endometrioid ovarian cancer and uterine adeno carcinoma in a young woman', Sultan Qaboos University Medical Journal, 3(1), pp. 51-53. doi:10.18295/2075-0528.2580.

Vancouver

Al-Moundhri M, Mathew M, Andrzej. Synchronous bilateral endometrioid ovarian cancer and uterine adeno carcinoma in a young woman. Sultan Qaboos University Medical Journal. 2025;3(1):51-53. doi:10.18295/2075-0528.2580

IEEE

M. Al-Moundhri, M. Mathew, and Andrzej, "Synchronous bilateral endometrioid ovarian cancer and uterine adeno carcinoma in a young woman," Sultan Qaboos University Medical Journal, vol. 3, no. 1, pp. 51-53, 2025, doi: 10.18295/2075-0528.2580.